John Reynders
John Reynders is Chief Data Scientist and Venture Partner at Iaso Ventures, a venture firm catalyzing biodigital innovation for next-gen life sciences. John is also the founder and CEO of Latent Strategies, LLC, an EdTech start-up combining artificial intelligence and game design to enable financial literacy education.
Previously, John served as the Chief Data Sciences Officer of Neumora Therapeutics, a biotech focused upon precision medicines for brain diseases. Prior to Neumora, John served as vice president, data sciences, genomics, and bioinformatics at Alexion where he led the design, building and deployment of data sciences solutions spanning R&D, commercial, strategy and business development. Prior to joining Alexion, John served as the founding chief information officer of Moderna Therapeutics, where he created a fully cloud-based biotech across all enterprise functions and developed informatics solutions to enable the design of messenger RNA therapeutics. Previously, John served as vice president of R&D information at AstraZeneca. Before this, John served in leadership roles at Johnson & Johnson including as vice president, integrative neuroscience and biomarkers, head of informatics and vice president of pharma R&D information technology. Previously, John served as information officer with Lilly Research Laboratories, vice president of informatics at Celera Genomics, and held roles as director and program manager at the Los Alamos National Laboratory.
John received his undergraduate degree in mathematics from Rensselaer Polytechnic Institute, a Ph.D. in applied and computational mathematics from Princeton University, and an MBA from the Northwestern University Kellogg School of Management.